Author:
Duzkopru Yakup,Kocanoglu Abdulkadir,Dogan Ozlem,Sahinli Hayriye,Cilbir Ebru,Altinbas Mustafa
Abstract
Pancreatic cancer (PanCa) presents a catastrophic disease with poor overall survival at advanced stages, with immediate requirement of new and effective treatment options. Besides genetic mutations, epigenetic dysregulation of signaling pathway-associated enriched genes are considered as novel therapeutic target. Mechanisms beneath the deoxyribonucleic acid methylation and its utility in developing of epi-drugs in PanCa are under trails. Combinations of epigenetic medicines with conventional cytotoxic treatments or targeted therapy are promising options to improving the dismal response and survival rate of PanCa patients. Recent studies have identified potentially valid pathways that support the prediction that future PanCa clinical trials will include vigorous testing of epigenomic therapies. Epigenetics thus promises to generate a significant amount of new knowledge of biological and medical importance. Our review could identify various components of epigenetic mechanisms known to be involved in the initiation and development of pancreatic ductal adenocarcinoma and related precancerous lesions, and novel pharmacological strategies that target these components could potentially lead to breakthroughs. We aim to highlight the possibilities that exist and the potential therapeutic interventions.
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,Oncology
Reference21 articles.
1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Stat Facts: Stomach Cancer. Surveillance, Epidemiology, and End Results (SEER) Program Cancer Stat Facts: Stomach Cancer, 2021
2. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
3. World Health Organization. International Agency for Research on Cancer. GLOBOCAN 2020: Stomach cancer fact sheet, 2020
4. Lauren classification and individualized chemotherapy in gastric cancer
5. Gastric Adenocarcinoma
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献